Ankylosing Spondylitis Trial, Recruiting (NCT07578220)

Ankylosing Spondylitis Trial, Recruiting NCT07578220 Sponsor: China-Japan Friendship Hospital Condition: Ankylosing Spondylitis

Printed from Voxsanity (voxsanity.com.au) — NCT07578220 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ankylosing Spondylitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) based on recognised medical criteria (confirm with trial site)
You are between 18 and 75 years old
Your disease activity score (called BASDAI) is 4 or higher, meaning your symptoms are moderately to severely active (confirm with trial site)
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have another autoimmune disease in addition to the condition being studied
You have complete fusion of the spine or significant spinal deformity
You are currently pregnant or breastfeeding
You have a serious heart or blood vessel condition, severe liver or kidney disease, cancer, or a blood clotting disorder
You are unable to take part in data collection due to mental health, language, or similar challenges
Your diagnosis is specifically psoriatic arthritis, reactive arthritis, or spondyloarthritis linked to inflammatory bowel disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13661102043

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07578220

Sponsor: China-Japan Friendship Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Ankylosing Spondylitis

Trial contact: +86 13661102043

More information: https://clinicaltrials.gov/study/NCT07578220

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) based on recognised medical criteria (confirm with trial site)
You are between 18 and 75 years old
Your disease activity score (called BASDAI) is 4 or higher, meaning your symptoms are moderately to severely active (confirm with trial site)
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have another autoimmune disease in addition to the condition being studied
You have complete fusion of the spine or significant spinal deformity
You are currently pregnant or breastfeeding
You have a serious heart or blood vessel condition, severe liver or kidney disease, cancer, or a blood clotting disorder
You are unable to take part in data collection due to mental health, language, or similar challenges
Your diagnosis is specifically psoriatic arthritis, reactive arthritis, or spondyloarthritis linked to inflammatory bowel disease

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

China-Japan Friendship Hospital

Registry

ClinicalTrials.gov

Start date

2 December 2025

Est. completion

30 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Bath Ankylosing Spondylitis Disease Activity Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov